Source: GWASDB

Variant Gene DSI v DPI v Chr Position Consequence Alleles Class AF EXOME AF GENOME Disease Score vda EI vda N. PMIDs First Ref. Last Ref.
dbSNP: rs2247056
rs2247056
HLA-B ; LINC02571 ; LOC112267902
0.882 0.160 6 31297713 intron variant T/C snv 0.80
CUI: C0202236
Disease: Triglycerides measurement
Triglycerides measurement 		0.800 1.000 1 2010 2018
dbSNP: rs4406273
rs4406273
HLA-B ; LINC02571 ; LOC112267902
0.925 0.040 6 31298313 intron variant G/A snv 8.6E-02
CUI: C0033860
Disease: Psoriasis
Psoriasis 		0.800 1.000 1 2012 2012
dbSNP: rs2894207
rs2894207
HLA-B ; LINC02571
0.882 0.160 6 31295974 intron variant T/C snv 0.20
CUI: C2931822
Disease: Nasopharyngeal carcinoma
Nasopharyngeal carcinoma 		0.720 1.000 1 2010 2018
dbSNP: rs2243868
rs2243868
HLA-B ; LINC02571
0.925 0.160 6 31293499 intron variant A/G snv 0.66
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis 		0.700 1.000 2 2007 2011
dbSNP: rs2524089
rs2524089
HLA-B ; LINC02571 ; LOC112267902
0.925 0.160 6 31298745 intron variant G/T snv 0.65
CUI: C0003873
Disease: Rheumatoid Arthritis
Rheumatoid Arthritis 		0.700 1.000 2 2007 2011
dbSNP: rs2524123
rs2524123
HLA-B ; LINC02571 ; LOC112267902
0.925 0.040 6 31297537 intron variant T/C snv 0.34
CUI: C1836233
Disease: AIDS, PROGRESSION TO
AIDS, PROGRESSION TO 		0.700 1.000 2 2009 2010
dbSNP: rs2524123
rs2524123
HLA-B ; LINC02571 ; LOC112267902
0.925 0.040 6 31297537 intron variant T/C snv 0.34
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO 		0.700 1.000 2 2009 2010
dbSNP: rs2524123
rs2524123
HLA-B ; LINC02571 ; LOC112267902
0.925 0.040 6 31297537 intron variant T/C snv 0.34
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
HIV-1, RESISTANCE TO 		0.700 1.000 2 2009 2010
dbSNP: rs2524123
rs2524123
HLA-B ; LINC02571 ; LOC112267902
0.925 0.040 6 31297537 intron variant T/C snv 0.34
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 		0.700 1.000 2 2009 2010
dbSNP: rs2894207
rs2894207
HLA-B ; LINC02571
0.882 0.160 6 31295974 intron variant T/C snv 0.20
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 		0.700 1.000 2 2009 2010
dbSNP: rs2894207
rs2894207
HLA-B ; LINC02571
0.882 0.160 6 31295974 intron variant T/C snv 0.20
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
HIV-1, RESISTANCE TO 		0.700 1.000 2 2009 2010
dbSNP: rs2894207
rs2894207
HLA-B ; LINC02571
0.882 0.160 6 31295974 intron variant T/C snv 0.20
CUI: C1836233
Disease: AIDS, PROGRESSION TO
AIDS, PROGRESSION TO 		0.700 1.000 2 2009 2010
dbSNP: rs2894207
rs2894207
HLA-B ; LINC02571
0.882 0.160 6 31295974 intron variant T/C snv 0.20
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO 		0.700 1.000 2 2009 2010
dbSNP: rs9366778
rs9366778
HLA-B ; LINC02571 ; LOC112267902
0.925 0.120 6 31301396 intron variant G/A snv 0.47
CUI: C1836233
Disease: AIDS, PROGRESSION TO
AIDS, PROGRESSION TO 		0.700 1.000 2 2009 2010
dbSNP: rs9366778
rs9366778
HLA-B ; LINC02571 ; LOC112267902
0.925 0.120 6 31301396 intron variant G/A snv 0.47
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 		0.700 1.000 2 2009 2010
dbSNP: rs9366778
rs9366778
HLA-B ; LINC02571 ; LOC112267902
0.925 0.120 6 31301396 intron variant G/A snv 0.47
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
HIV-1, RESISTANCE TO 		0.700 1.000 2 2009 2010
dbSNP: rs9366778
rs9366778
HLA-B ; LINC02571 ; LOC112267902
0.925 0.120 6 31301396 intron variant G/A snv 0.47
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO 		0.700 1.000 2 2009 2010
dbSNP: rs13191519
rs13191519
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31297975 intron variant T/C snv 0.12
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
HIV-1, RESISTANCE TO 		0.700 1.000 1 2009 2009
dbSNP: rs13191519
rs13191519
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31297975 intron variant T/C snv 0.12
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO 		0.700 1.000 1 2009 2009
dbSNP: rs13191519
rs13191519
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31297975 intron variant T/C snv 0.12
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 		0.700 1.000 1 2009 2009
dbSNP: rs13191519
rs13191519
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31297975 intron variant T/C snv 0.12
CUI: C1836233
Disease: AIDS, PROGRESSION TO
AIDS, PROGRESSION TO 		0.700 1.000 1 2009 2009
dbSNP: rs13216197
rs13216197
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31303241 intron variant T/C snv 0.15
CUI: C1836232
Disease: ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO 		0.700 1.000 1 2009 2009
dbSNP: rs13216197
rs13216197
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31303241 intron variant T/C snv 0.15
CUI: C1836231
Disease: HIV-1, RESISTANCE TO
HIV-1, RESISTANCE TO 		0.700 1.000 1 2009 2009
dbSNP: rs13216197
rs13216197
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31303241 intron variant T/C snv 0.15
CUI: C1836230
Disease: HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO 		0.700 1.000 1 2009 2009
dbSNP: rs13216197
rs13216197
HLA-B ; LINC02571 ; LOC112267902
1.000 6 31303241 intron variant T/C snv 0.15
CUI: C1836233
Disease: AIDS, PROGRESSION TO
AIDS, PROGRESSION TO 		0.700 1.000 1 2009 2009